Jafron Biomedical Co Ltd (300529)

Currency in CNY
16.20
+0.16(+1.00%)
Closed·
300529 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.0516.50
52 wk Range
14.7324.98
Key Statistics
Bid/Ask
16.19 / 16.21
Prev. Close
16.04
Open
16.05
Day's Range
16.05-16.5
52 wk Range
14.73-24.98
Volume
7.07M
Average Volume (3m)
5.86M
1-Year Change
-24.1928%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300529 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
24.12
Upside
+48.86%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 24.12
(+48.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 28, 2026
EPS / Forecast
0.28 / --
Revenue / Forecast
561M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.74%
Dividend Yield
3.24%
Industry Median 1.84%
Annualised payout
0.52
Paid annually
5-Years Growth
-4.66%
Growth Streak

300529 Income Statement

Compare 300529 to Peers and Sector

Metrics to compare
300529
Peers
Sector
Relationship
P/E Ratio
22.0x22.0x−0.4x
PEG Ratio
−1.10−0.690.00
Price/Book
3.4x1.9x2.6x
Price / LTM Sales
6.1x5.2x3.0x
Upside (Analyst Target)
50.3%46.5%51.3%
Fair Value Upside
Unlock16.4%7.3%Unlock

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Employees
2301
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
65.75M8.49%1.05B
Other Institutional Investors
8.08M1.04%129.54M
Public Companies & Retail Investors
700.53M90.47%11.24B
Total
774.36M100.00%12.42B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Hwabao WP Fund Management Co., Ltd1.74%13,499,351216,530
Hwabao CSI Medical ETF1.74%13,499,351216,530

People Also Watch

33.56
603288
+0.24%
29.49
000963
-0.27%
12.78
002007
+1.43%
69.89
000408
+2.30%

FAQ

What Is the Jafron Biomedical (300529) Stock Price Today?

The Jafron Biomedical stock price today is 16.20 CNY.

What Stock Exchange Does Jafron Biomedical Trade On?

Jafron Biomedical is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Jafron Biomedical?

The stock symbol for Jafron Biomedical is "300529."

What Is the Jafron Biomedical Market Cap?

As of today, Jafron Biomedical market cap is 12.54B CNY.

What Is Jafron Biomedical's Earnings Per Share (TTM)?

The Jafron Biomedical EPS (TTM) is 0.74.

When Is the Next Jafron Biomedical Earnings Date?

Jafron Biomedical will release its next earnings report on Aug 21, 2026.

From a Technical Analysis Perspective, Is 300529 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Jafron Biomedical Stock Split?

Jafron Biomedical has split 1 times.

How Many Employees Does Jafron Biomedical Have?

Jafron Biomedical has 2301 employees.

What is the current trading status of Jafron Biomedical (300529)?

As of Jul 02, 2026, Jafron Biomedical (300529) is trading at a price of 16.20 CNY, with a previous close of 16.04 CNY. The stock has fluctuated within a day range of 16.05 CNY to 16.50 CNY, while its 52-week range spans from 14.73 CNY to 24.98 CNY.

What Is Jafron Biomedical (300529) Price Target According to Analysts?

The average 12-month price target for Jafron Biomedical is 24.12 CNY, with a high estimate of 24.23 CNY and a low estimate of 24 CNY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +48.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.